Tau Therapeutics' Merger

Tau Therapeutics raised a round of funding on August 28, 2014. Investors include Cavion.

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, …

Articles about Tau Therapeutics' Merger: